MA24794A1 - D-methadone, un analgesique nonopioique - Google Patents

D-methadone, un analgesique nonopioique

Info

Publication number
MA24794A1
MA24794A1 MA24934A MA24934A MA24794A1 MA 24794 A1 MA24794 A1 MA 24794A1 MA 24934 A MA24934 A MA 24934A MA 24934 A MA24934 A MA 24934A MA 24794 A1 MA24794 A1 MA 24794A1
Authority
MA
Morocco
Prior art keywords
alpha
subject
methadone
nonopioic
analgesic
Prior art date
Application number
MA24934A
Other languages
English (en)
Original Assignee
Cornell Res Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cornell Res Foundation Inc filed Critical Cornell Res Foundation Inc
Publication of MA24794A1 publication Critical patent/MA24794A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MA24934A 1997-01-22 1998-01-22 D-methadone, un analgesique nonopioique MA24794A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3530897P 1997-01-22 1997-01-22

Publications (1)

Publication Number Publication Date
MA24794A1 true MA24794A1 (fr) 1999-12-31

Family

ID=21881853

Family Applications (1)

Application Number Title Priority Date Filing Date
MA24934A MA24794A1 (fr) 1997-01-22 1998-01-22 D-methadone, un analgesique nonopioique

Country Status (12)

Country Link
US (1) US6008258A (fr)
EP (1) EP1003494B1 (fr)
JP (2) JP4514241B2 (fr)
AT (1) ATE357226T1 (fr)
AU (1) AU6244898A (fr)
CA (1) CA2278422C (fr)
DE (1) DE69837387T2 (fr)
DK (1) DK1003494T3 (fr)
ES (1) ES2283049T3 (fr)
MA (1) MA24794A1 (fr)
PT (1) PT1003494E (fr)
WO (1) WO1998031358A1 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070197651A1 (en) * 1998-03-09 2007-08-23 Tufts University Treatment of stereotypic, self-injurious and compulsive behaviors in man and animals using antagonists of NMDA receptors
US20060167114A1 (en) * 1998-03-09 2006-07-27 Louis Shuster Treatment of stereotypic, self-injurious and compulsive behaviors in man and animals using antagonists of NMDA receptors
AU2981099A (en) * 1998-03-09 1999-09-27 Trustees Of Tufts College Treatment of compulsive behaviours in man and animals
CN1309562A (zh) * 1998-07-16 2001-08-22 纪念斯隆-凯特林癌症中心 包括一种阿片样物质镇痛剂和一种nmda拮抗剂的局部给药组合物
US6897242B1 (en) * 1999-02-24 2005-05-24 Judson J. Somerville Non-racemic mixtures of d- and l- methadone and method of treating pain
WO2001076522A1 (fr) * 2000-04-07 2001-10-18 Ultramed International, Inc. Maintien de l'abstinence apres sevrage des dependances aux opiacees
JP2004512260A (ja) 2000-04-28 2004-04-22 メモリアル　スローン−ケッタリング　キャンサー　センター 局所麻酔／オピオイド製剤およびその使用方法
US7820688B2 (en) 2001-04-27 2010-10-26 Memorial Sloan-Kettering Cancer Center Topical anesthetic/opioid formulations and uses thereof
CA2473536A1 (fr) * 2002-01-16 2003-07-31 Endo Pharmaceuticals, Inc. Composition pharmaceutique et methode de traitement de troubles du systeme nerveux central
EP1476155A4 (fr) * 2002-01-23 2009-10-28 Univ California Procedes et compositions destines a reduire le developpement de tolerance au medicament et/ou de dependance physique
US20060058331A1 (en) * 2002-05-13 2006-03-16 Bradley Galer Abuse resistant opioid dosage form
EP1545461A4 (fr) * 2002-09-09 2011-06-22 Endo Pharmaceuticals Inc Composition analgesique combinee a liberation immediate et prolongee
US20040180915A1 (en) * 2003-03-14 2004-09-16 Xanodyne Pharmacal, Inc. Methadone-containing compositions for parenteral administration and method of use thereof
US20040202717A1 (en) 2003-04-08 2004-10-14 Mehta Atul M. Abuse-resistant oral dosage forms and method of use thereof
US20100010096A1 (en) * 2006-10-27 2010-01-14 John Charin Somberg Methadone chiral isolate as an improved pharmaceutical
WO2008073381A2 (fr) * 2006-12-11 2008-06-19 University Of Kentucky Research Foundation Effets synergiques d'associations de nornicotine et d'opioïdes contre la douleur
US9468611B2 (en) 2012-09-27 2016-10-18 Relmada Therapeutics, Inc. d-Methadone for the treatment of psychiatric symptoms
KR20190124722A (ko) * 2017-01-31 2019-11-05 파올로 엘. 만프레디 신경계 장애의 치료에서 사용하기 위한 ｄ-메타돈 및 이의 유도체
WO2018183320A1 (fr) * 2017-03-31 2018-10-04 Depco, Inc. Mastic thérapeutique à analgésiques et/ou révulsifs
CN113646044A (zh) * 2019-01-30 2021-11-12 帕多瓦大学 用于预防和治疗疾病和病症的结构修饰的阿片类药物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3895056A (en) * 1972-12-26 1975-07-15 Lilly Co Eli Alpha-d1-4-acetoxy-1-methyl-3,3-diphenylhexylamine and salts
US5321012A (en) * 1993-01-28 1994-06-14 Virginia Commonwealth University Medical College Inhibiting the development of tolerance to and/or dependence on a narcotic addictive substance
US5352683A (en) * 1993-03-05 1994-10-04 Virginia Commonwealth University Medical College Of Virginia Method for the treatment of chronic pain
CA2115792C (fr) * 1993-03-05 2005-11-01 David J. Mayer Methode de traitement de la douleur

Also Published As

Publication number Publication date
ATE357226T1 (de) 2007-04-15
PT1003494E (pt) 2007-06-06
DE69837387T2 (de) 2007-12-13
ES2283049T3 (es) 2007-10-16
EP1003494A1 (fr) 2000-05-31
JP2010013477A (ja) 2010-01-21
CA2278422C (fr) 2007-11-13
DK1003494T3 (da) 2007-07-16
CA2278422A1 (fr) 1998-07-23
JP4514241B2 (ja) 2010-07-28
JP2001508797A (ja) 2001-07-03
EP1003494B1 (fr) 2007-03-21
US6008258A (en) 1999-12-28
EP1003494A4 (fr) 2002-10-16
DE69837387D1 (de) 2007-05-03
AU6244898A (en) 1998-08-07
WO1998031358A1 (fr) 1998-07-23

Similar Documents

Publication Publication Date Title
DK1003494T3 (da) (d)-metadon, et ikke-opioidt analgetikum
NZ331189A (en) Method of detection of influenza virus using neuraminidase binders
IL128003A (en) MULTISPECIFIC BINDING MOLECULES COMPRISING A BINDING DETERMINANT WHICH BINDS AN FCalpha RECEPTOR
FR12C0001I2 (fr) Anticorps se liant de maniere immunospecifique a un stimulateur de lymphocyte b
ATE301994T1 (de) Verfahren zur erleichterung von schmerzen durch eine kombination von tramadol und einen nmda- antagonist
FI965203A7 (fi) Morfiinia, polypyrrolidonia ja polyalkyleenioksidia sisältävä koostumus
CA2146973A1 (fr) Utilisations d'un fragment du recepteur du tgf-.beta. a des fins therapeutiques
DE69733081D1 (de) Antikonvulsive mitteln enthaltende zubereitung zur behandlung von neuropathischen schmerzen
BR9910180A (pt) Composição farmacêutica, processos para o tratamento de uma condição associada com a transmissão reduzida de nicotina, para identificação de um modulador positivo de um agonista receptor nicotìnico e para identificação de um composto, composto, e, uso de um modulador positivo de um agonista receptor nicotìnico
IT8822374A0 (it) Procedimento per distribuire, su richiesta, copie di documenti immagazzinati in forma leggibile da macchina.
AU1718400A (en) Method for treating pain
TR200000755T2 (tr) Karşıt olma-karşı gelme bozukluğunun tedavisi.
UA26403A (uk) Похідhі n-заміщеhого 4-феhіл-4-піперидиhкарбоксаміду та їх фармацевтичhо прийhятhі солі, що проявляють аhестезувальhу та аhальгезувальhу дію, спосіб їх одержаhhя та фармацевтичhа композиція
DK1063995T3 (da) Kombination til behandling af alkoholafhængighed indeholdende en opiod-antagonist og en NMDA-receptorkompleks-modulator
ATE221391T1 (de) Konjugat enthaltend dtpa und albumin zur individuellen dosierung von arzneimitteln
DE69711078D1 (de) Topische verwendung von kappa-opioidrezeptoragonisten zur behandlung von augenschmerz
DK0846173T3 (da) Anvendelse af et anti-interleukin-9-antistof til fremstilling af et lægemiddel til behandling af astma
EA199800866A1 (ru) Способ снятия боли
SE9501881D0 (sv) New pharmacological use of AII-receptor antagonists
MY133169A (en) Substituted heterocyclic benzocycloalkenes and the use thereof as substances having an analgesic effect
WO1998020835A3 (fr) Methode pour traiter l'hyperlipidemie chez l'homme
CA2299400A1 (fr) Methode de traitement de dyskinesies liees a une maladie ou provoquees par l'absorption de medicaments
EA199800535A1 (ru) Способ лечения боли
WO2000051632A3 (fr) Agoniste du cuivre qui se lie au site de fixation de cuivre de l'app et/ou exerce une action d'inhibition sur la liberation du peptide beta-amyloide
AU4937499A (en) Use of succinic acid or salts thereof and method of treating insulin resistance